Should BTKi therapy be discontinued in CLL? VJHemOnc – Video Journal of Hematology & HemOnc 3:07 3 months ago 162 Далее Скачать
The real-world outcomes of patients with CLL who discontinue BTKi therapy VJHemOnc – Video Journal of Hematology & HemOnc 1:45 7 months ago 128 Далее Скачать
Duration of BTKi therapy correlates with time to next treatment in CLL | Kerry Rogers, MD | #ASH24 HealthTree Foundation for Blood Cancers 8:57 10 days ago 20 Далее Скачать
Continuous BTKi therapy in CLL: are time-limited combination therapies more beneficial? VJHemOnc – Video Journal of Hematology & HemOnc 2:56 3 months ago 150 Далее Скачать
BTKi discontinuation in CLL: intolerance & disease progression VJHemOnc – Video Journal of Hematology & HemOnc 2:13 3 years ago 159 Далее Скачать
Chronic Lymphocytic Leukemia: Treatment Options for BTKi Progressors HMP Education 16:58 3 years ago 722 Далее Скачать
Managing the side effects associated with BTKi treatment for CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:46 11 months ago 482 Далее Скачать
Part 2 - How do I use BTKi for CLL management? - Dr. Nitin Jain, USA MICE IDEAS 32:51 3 years ago 220 Далее Скачать
Update on BTK inhibitors for CLL: Ibrutinib pus the new kids on the block: Are they better? HMP Education 21:42 6 years ago 3 664 Далее Скачать
Overcoming challenges with targeted therapies for CLL: high-risk mutations and BTKi resistance VJHemOnc – Video Journal of Hematology & HemOnc 3:09 3 months ago 60 Далее Скачать
Taking the Next Steps With Next-Generation BTKi in CLL, MCL, and DLBCL PeerView Oncology 48:43 1 year ago 296 Далее Скачать
Cardiovascular adverse events following treatment with BTK inhibitors in CLL & MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:21 1 year ago 214 Далее Скачать
Time-limited vs continuous therapy in CLL treatment VJHemOnc – Video Journal of Hematology & HemOnc 1:34 2 years ago 228 Далее Скачать
Treating CLL after intolerance or progression on BTKi VJHemOnc – Video Journal of Hematology & HemOnc 4:10 3 years ago 133 Далее Скачать
BTKi Resistance Mutations in Chronic Lymphocytic Leukemia (CLL) CLL Society 30:28 3 months ago 560 Далее Скачать
Clinical outcomes of BTKi + Ven treatment in CLL/SLL: double-exposed vs double-refractory patients VJHemOnc – Video Journal of Hematology & HemOnc 1:53 1 year ago 145 Далее Скачать
Outcomes of patients with CLL discontinuing BTK inhibitors due to adverse effects VJHemOnc – Video Journal of Hematology & HemOnc 1:12 1 month ago 68 Далее Скачать
Rewriting the Script in CLL With Modern Targeted and Next-Gen Options PeerView Oncology 1:29:37 2 years ago 1 880 Далее Скачать
